Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

CTSO holding history

Cytosorbents Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTSO overviewAll 13F holders of CTSOFull Q2 2026 holdings

Shares (Q2 2026)
131,019
Value
$49.0K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CTSO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026131,019$49.0K<0.1%+15,819+13.7%AddedHolders
Q1 2026115,200$65.2K<0.1%−72−0.1%ReducedHolders
Q4 2025115,272$73.7K<0.1%+69+0.1%AddedHolders
Q3 2025115,203$107.6K<0.1%−7,129−5.8%ReducedHolders
Q2 2025122,332$156.6K<0.1%+7,132+6.2%AddedHolders
Q1 2025115,200$115.2K<0.1%−29,725−20.5%ReducedHolders
Q4 2024144,925$131.9K<0.1%+142,354+5,536.9%AddedHolders
Q3 20242,571$3.86K<0.1%+714+38.4%AddedHolders
Q2 20241,857$1.30K<0.1%+1,800+3,157.9%AddedHolders
Q1 202457$54<0.1%−2,904−98.1%ReducedHolders
Q4 20232,961$3.29K<0.1%+2,764+1,403.0%AddedHolders
Q3 2023197$370<0.1%−928−82.5%ReducedHolders
Q2 20231,125$4.04K<0.1%+645+134.4%AddedHolders
Q1 2023480$1.62K<0.1%−3,066−86.5%ReducedHolders
Q4 20223,546$5.50K<0.1%−2,112−37.3%ReducedHolders
Q3 20225,658$7.00K<0.1%+5,200+1,135.4%AddedHolders
Q2 2022458$1.00K<0.1%−2,735−85.7%ReducedHolders
Q1 20223,193$10.0K<0.1%−8,060−71.6%ReducedHolders
Q4 202111,253$48.0K<0.1%+9,654+603.8%AddedHolders
Q3 20211,599$13.0K<0.1%−1,819−53.2%ReducedHolders
Q2 20213,418$26.0K<0.1%−4,164−54.9%ReducedHolders
Q1 20217,582$66.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.